Clinical Features of Unrecognized Congenital Adrenal Hyperplasia due to 17α-hydroxylase Deficiency Since Adolescence:
A Case Report
DOI:
https://doi.org/10.15605/jafes.038.02.08Keywords:
disorders of sexual development, DSD, congenital adrenal hyperplasia, rare cases, hypertension, 46,XY DSD, 17α-hydroxylase deficiencyAbstract
The majority of patients with congenital adrenal hyperplasia (CAH) present with a deficiency of 21-hydroxylase or 11-beta-hydroxylase, which account for 90% and 7% of cases, respectively. However, CAH due to 17α-hydroxylase deficiency (17OHD) is an extremely rare form of CAH (<1% of all CAH cases) that leads to a deficiency of cortisol and sex steroids, along with features of aldosterone excess. This is a case of a 51-year-old single female who was referred to us for the evaluation of new-onset hypertension and hypokalaemia of one-year duration. She was born out of a second-degree consanguineous marriage and reared as a female. She was diagnosed to have testicular feminization syndrome when she presented with a history of primary amenorrhea, absence of secondary sexual characteristics, and bilateral labial swellings at pubertal age. Subsequently, she underwent gonadectomy at the age of 16. Due to the presence of hypertension, metabolic alkalosis and bilaterally enlarged adrenals on CT scan, 46, XY disorders of sexual development (DSD) was considered. A karyotype confirmed the presence of 46, XY chromosomal sex, and genetic analysis revealed a mutation in the CYP17A1 gene, thus confirming the diagnosis of 17a-hydroxylase deficiency.
Downloads
References
Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125-36. https://pubmed.ncbi.nlm.nih.gov/15964450. https://doi.org/10.1016/S0140-6736(05)66736-0.
Krone N, Arlt W. Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):181-92. https://pubmed.ncbi.nlm.nih.gov/19500762. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576025. https://doi.org/10.1016/j.beem.2008.10.014.
Costa-Santos M, Kater CE, Auchus RJ; Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab. 2004;89(1):49-60. https://pubmed.ncbi.nlm.nih.gov/14715827. https://doi.org/10.1210/jc.2003-031021.
Chapla A, Mruthyunjaya MD, Asha HS, et al. Maturity onset diabetes of the young in India - A distinctive mutation pattern identified through targeted next-generation sequencing. Clin Endocrinol (Oxf). 2015;82(4):533-42. https://pubmed.ncbi.nlm.nih.gov/25041077. https://doi.org/10.1111/cen.12541.
Mikami Y, Takai Y, Obata-Yasuoka M, et al. Diagnosis of female 17α-hydroxylase deficiency after gonadectomy: A case report. J Med Case Rep. 2019;13(1):235. https://pubmed.ncbi.nlm.nih.gov/31358067. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664496. https://doi.org/10.1186/s13256-019-2166-9.
Croxson M, Ogilvie CM, Milsom S, Lewis J, Davidson J, Rumsby G. Delayed puberty from partial 17-alpha hydroxylase enzyme deficiency. N Z Med J. 2012;125(1355):71-4. https://pubmed.ncbi.nlm.nih.gov/22722218.
Yanase T, Kagimoto M, Suzuki S, Hashiba K, Simpson ER, Waterman MR. Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Biol Chem. 1989;264(30):18076-82. Erratum in: J Biol Chem 1989;264(35):21433. https://pubmed.ncbi.nlm.nih.gov/2808364.
Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man. J Clin Invest. 1966;45(12):1946-54. https://pubmed.ncbi.nlm.nih.gov/4288776. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC292880. https://doi.org/10.1172/JCI105499.
Maheshwari M, Arya S, Lila AR, et al. 17α-Hydroxylase/17,20-lyase deficiency in 46,XY: Our experience and review of literature. J Endocr Soc. 2022;6(3):bvac011. https://pubmed.ncbi.nlm.nih.gov/35178494. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845120. https://doi.org/10.1210/jendso/bvac011.
Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017;165(Pt A):71-8. https://pubmed.ncbi.nlm.nih.gov/26862015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976049. https://doi.org/10.1016/j.jsbmb.2016.02.002.
Kim YM, Kang M, Choi JH, et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metabolism. 2014;63(1):42-9. https://pubmed.ncbi.nlm.nih.gov/24140098. https://doi.org/10.1016/j.metabol.2013.08.015.
Kim SM, Rhee JH. A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015;42(2):72-6. https://pubmed.ncbi.nlm.nih.gov/26161337. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496435. https://doi.org/10.5653/cerm.2015.42.2.72.
Zhang M, Sun S, Liu Y, et al. New, recurrent, and prevalent mutations: Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase/17,20-lyase deficiency. J Steroid Biochem Mol Biol. 2015 Jun;150:11-6. https://pubmed.ncbi.nlm.nih.gov/25697092. https://doi.org/10.1016/j.jsbmb.2015.02.007.
Asirvatham AR, Balachandran K, Jerome P, Venkatesan V, Koshy T, Mahadevan S. Clinical, biochemical and genetic characteristics of children with congenital adrenal hyperplasia due to 17α-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2020 Jul 13;/j/jpem.ahead-of-print/jpem-2020-0050/jpem-2020-0050.xml. https://pubmed.ncbi.nlm.nih.gov/32651986. https://doi.org/10.1515/jpem-2020-0050.
Wilson JD, Rivarola MA, Mendonca BB, et al. Advice on the management of ambiguous genitalia to a young endocrinologist from experienced clinicians. Semin Reprod Med. 2012;30(5):339–50. https://pubmed.ncbi.nlm.nih.gov/23044870. https://doi.org/10.1055/s-0032-1324717.
Jiang JF, Deng Y, Xue W, Wang YF, Tian QJ, Sun AJ. Surgical therapy of 17α-hydroxylase deficiency in 30 patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2016; 38(5):559–62. https://pubmed.ncbi.nlm.nih.gov/27825414. https://doi.org/10.3881/j.issn.1000-503X.2016.05.012.
Wisniewski AB, Batista RL, Costa EMF, et al. Management of 46,XY differences/disorders of sex development (DSD) throughout life. Endocr Rev. 2019;40(6):1547-72. https://pubmed.ncbi.nlm.nih.gov/31365064. https://doi.org/10.1210/er.2019-00049.
Wiesemann C, Ude-Koeller S, Sinnecker GHG, Thyen U. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. Eur J Pediatr. 2010;169(6):671-9. https://pubmed.ncbi.nlm.nih.gov/19841941. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859219. https://doi.org/10.1007/s00431-009-1086-x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rashmi K G, Lavanya Ravichandran, Ayan Roy, Dukhabandhu Naik, Sadishkumar Kamalanathan, Jayaprakash Sahoo, Aaron Chapla, Nihal Thomas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.